South Africa: The Intention To Become A Substantive Search And Examination Office

South Africa has a depository patent system, which means that patent applications made to the South African patent office are merely examined for compliance with the requisite formalities deemed necessary for the grant of a patent (i.e. consideration as to whether the correct official forms and fees).

Therefore, albeit that novelty, inventiveness (non-obviousness) and industrial applicability (Patent Act 57 of 1978 s25(1)) are a requirement in terms of the Patent Act 57 of 1978 (The Act). For patentability, no substantive search and examination of patent applications takes place in South Africa to verify that a patent application meets these requirements prior to the granting of the same. Potentially, this means that there could be a large number of granted patents on the South African Patents Registry that would not pass muster in examining jurisdictions. The patentability of a patent in South Africa can only be challenged post-grant via the court system. Arguments are made that this process is costly and can be protracted, hence is not facilitative enough to promote challenges being made to patents on the basis of their patentability (Reforming South Africa's processing for granting patents to improve medicine access. S Afr Med J 2015;105(9):741-743) by individuals and by smaller businesses.

The issue of formal versus substantive patent examination in South Africa has seen much debate in recent years, as this issue is seen as a critical issue with respect to the access to affordable medicines. Activists, such as the Treatment Action Campaign (TAC), have argued that the lack of substantive examination in South Africa allows for the registration of potentially invalid patents by large pharmaceutical companies, which hikes up the prices of medicines making the same inaccessible to a large portion of the population and, in some instances, even affects the availability of such medicines within the public health system (Why Should South Africa Examine Pharmaceutical Patents? Briefing by TAC, MSF and RIS – January 2013). This is also considered an important policy issue within government. Proponents of these groups are of the view that substantive examination will prevent the registration of invalid patents and therefore perhaps allow for the entry of generic versions of these medicines into South Africa much sooner, which would then also influence the price of such medicines and, by inference, the access thereto (IBID).

As a means to address the various concerns raised about a need for patent law reform in South Africa, the Department of Trade and Industry (DTI) has issued three draft policies, the first in 2013, the second late last year, and the latest during the course of August 2017. The latter two policies are pertinent with respect to the issue of substantive examination.

The policies make it clear that the DTI are working towards implementing substantive examination in South Africa (Intellectual Property Consultative Framework – 6 July 2016). It is recognized that the current depository system places the costs associated with substantive examination (in the courts) on the party or parties challenging the validity of the patent, whereas there will be an increase in costs to the state under a substantive examination system (and also to applicants who will have to pay the prices associated with examination). It is also recognized that a substantive system will be more onerous for the state from a capacity point of view, hence there will be a need to implement a system that avoids backlogs in the granting of patents, whilst maintaining a high standard of examination. In order to avoid capacity constraints, the 2016 framework proposed two possible solutions (Intellectual Property Consultative Framework – 6 July 2016 paragraph 4.1.2.):

  1. Prioritization of substantive examination for certain technology sectors

    The idea behind this prioritization would be to implement substantive examination of pharmaceutical patent applications first and then to build up capacity slowly such that eventually all patent applications can be examined. It is argued in the framework that this amounts to differentiation and not discrimination, hence is allowable in terms of Art 27.1 of TRIPS (TRIPS: The Agreement on Trade-Related Aspects of Intellectual Property Rights to which South Africa is a signatory).
  2. As a contingency against a backlog, to outsource examination to certain patent offices that are known to be highly efficient

    No mention is made as to the possible cost implications associated with such outsourcing or to which offices would be considered candidates for such outsourcing. The 2017 (Draft Intellectual Property Policy of the Republic of South Africa –Phase I – August 2017) policy which focuses on a number of strategic objectives which are to be rolled out in a phased approach on the issue of SSE favors the first approach and reinforces that this amounts to differentiation between sectors for legitimate reasons rather than discrimination. The phased approach will focus on the most pertinent sectors first and gradually expand to include all sectors as capacity grows.

Alternative approaches to dealing with the possible capacity constraints have been suggested by interested stakeholders. These include a collaborative approach whereby examination reports issued in substantive examination jurisdictions are accepted for the purposes of showing patentability in South Africa (Reforming South Africa's processing for granting patents to improve medicine access. S Afr Med J 2015;105(9):741-743). This approach would have to be carefully considered, such that only foreign jurisdictions that have patent laws substantially aligned with the laws in South Africa would be appropriate for such collaboration. The Companies and Intellectual Property Commission (CIPC), which handles, amongst other things, the administration of the patent system in South Africa, has hired twenty technically qualified individuals who are currently in the process of training to be the first patent examiners in South Africa. Therefore, it is clear that there is a very real intention to move forward with substantive examination in South Africa.

Precisely what this will mean from both a capacity point of view in the South African patent office and from a cost point of view for applicants is uncertain. However, it is clear that these answers are on the horizon. Dennemeyer & Associates South Africa, together with the rest of the Dennemeyer group worldwide, is well placed to help both local and foreign applicants in navigating these new waters, as the group has extensive experience in a variety of substantive examining jurisdictions, which will stand it in very good stead when substantive examination arrives in South Africa.

The article first appeared in The Patent Lawyer Magazine, September 2017 issue.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Adams & Adams
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Adams & Adams
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions